SBC Medical Group Holdings Incorporated
SBC
$3.69
-$0.04-1.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 44.42M | 53.08M | 53.10M | 54.81M | 62.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.42M | 53.08M | 53.10M | 54.81M | 62.35M |
| Cost of Revenue | 10.55M | 9.85M | 13.68M | 15.29M | 18.98M |
| Gross Profit | 33.87M | 43.24M | 39.42M | 39.52M | 43.37M |
| SG&A Expenses | 28.40M | 29.25M | 11.98M | 14.96M | 39.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -205.80K | 151.60K | 149.30K | 100.10K | -1.17M |
| Total Operating Expenses | 24.64M | 39.25M | 25.81M | 30.35M | 38.36M |
| Operating Income | 19.78M | 13.83M | 27.29M | 24.46M | 23.99M |
| Income Before Tax | 6.06M | 13.11M | 27.09M | 27.20M | 23.57M |
| Income Tax Expenses | -488.60K | 10.27M | 8.53M | 8.45M | 9.34M |
| Earnings from Continuing Operations | 6.55M | 2.83M | 18.56M | 18.75M | 14.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -8.70K | -1.60K | -72.90K | 7.50K | 112.60K |
| Net Income | 6.54M | 2.83M | 18.48M | 18.76M | 14.34M |
| EBIT | 19.78M | 13.83M | 27.29M | 24.46M | 23.99M |
| EBITDA | 20.71M | 14.85M | 28.12M | 25.48M | 26.55M |
| EPS Basic | 0.06 | 0.03 | 2.33 | 2.36 | 0.15 |
| Normalized Basic EPS | 0.26 | 0.09 | 2.12 | 1.91 | 0.31 |
| EPS Diluted | 0.12 | 0.03 | 2.33 | 2.36 | 0.15 |
| Normalized Diluted EPS | 0.26 | 0.09 | 2.12 | 1.91 | 0.31 |
| Average Basic Shares Outstanding | 102.76M | 95.10M | 7.95M | 7.95M | 94.19M |
| Average Diluted Shares Outstanding | 102.76M | 95.10M | 7.95M | 7.95M | 94.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |